Retrospective analysis of multi-institutional, patient-specific treatment planning results of high-dose-rate intracavitary brachytherapy for gynecological cancer using V100%-Reference-Cited by-同舟云学术

Retrospective analysis of multi-institutional, patient-specific treatment planning results of high-dose-rate intracavitary brachytherapy for gynecological cancer using V100%

Published:2018-10-25 Issue:4 Volume:41 Page:1069-1074
ISSN:0158-9938
Container-title:Australasian Physical & Engineering Sciences in Medicine
language:en
Short-container-title:Australas Phys Eng Sci Med

Author:

Watanabe Tetsuya^ORCID,Miyashita Hisayuki,Notake Ryoichi,Todoroki Keisuke,Nakajima Go,Washizu Kana,Utsumi Nobuko,Hatanaka Shogo,Hariu Masatsugu,Yamano Takafumi,Nishimura Keiichiro,Shimbo Munefumi,Takahashi Takeo

Publisher

Springer Science and Business Media LLC

Subject

Radiology Nuclear Medicine and imaging,Biomedical Engineering,Biophysics,General Physics and Astronomy

Link

http://link.springer.com/article/10.1007/s13246-018-0701-4/fulltext.html

Reference16 articles.

1. Stitt JA, Fowler JF, Thomadsen BR et al (1992) High dose rate intracavitary brachytherapy for carcinoma of the cervix: the Madison system: I. Clinical and radiobiological considerations. Int J Radiat Oncol Biol Phys 24:335–348

2. U.S. Nuclear Regulatory Commission (2003) Medical use of by-product material. Title 10, Chap. 1, Code of Federal Regulations d Energy. Part 35. Government Printing Office, Washington, DC

3. Takahashi Y, Koizumi M, Sumida I et al (2012) The usefulness of an independent patient-specific treatment planning verification method using a benchmark plan in high-dose-rate intracavitary brachytherapy for carcinoma of the uterine cervix. J Radiat Res 53:936–944

4. Das RK, Bradley KA, Nelson IA et al (2006) Quality assurance of treatment plans for interstitial and intracavitary high-dose-rate brachytherapy. Brachytherapy 5:56–60

5. Thomadosen BR, Shahabi S, Stitt JA et al (1992) High dose rate intracavitary brachytherapy for carcinoma of the cervix: the Independent patient-specific treatment planning verification method using a benchmark plan 943 Madison system: II. Procedural and physical considerations. Int J Radiat Oncol Biol Phys 24:349–357